S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68
S&P 500   3,901.36
DOW   31,261.90
QQQ   288.68

International Biotechnology Trust (IBT) Share Forecast, Price & News

GBX 620
0.00 (0.00%)
(As of 05/20/2022 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
34,064 shs
Average Volume
84,671 shs
Market Capitalization
£253.49 million
P/E Ratio
Dividend Yield
30 days | 90 days | 365 days | Advanced Chart
Receive IBT News and Ratings via Email

Sign-up to receive the latest news and ratings for International Biotechnology Trust and its competitors with MarketBeat's FREE daily newsletter.

International Biotechnology Trust logo

About International Biotechnology Trust

International Biotechnology Trust plc specializes in investments in development stage and late stage companies. The majority of the fund's assets are generally invested in smaller and mid-capitalization quoted companies, with a minority in larger capitalization quoted companies. It makes long only investments. It prefers to invest in quoted or unquoted biotechnology and life sciences companies focused on drug discovery and development and in related sectors such as microbiology, life sciences, pharmaceutical research and development, gene research and development, medical devices or healthcare services. The fund seeks to invest in companies engaged in development and/or commercialization of a product, device or enabling technology and also invests in the therapeutic sub-sector. The fund also prefers to invest in companies with strong growth potential from the development and/or commercialization of either a biotechnology drug candidate, medical device or other enabling technology for medical research. It may also invest in specialty pharmaceuticals and life science tools. These companies can range from small private companies with strong science and people that need development funding, to large, multi-billion dollar biotechnology and medical device companies which have portfolios of products, many of which are already used in hospitals, clinics and pharmacies around the world. It makes majority of its investments in smaller and mid-capitalization quoted companies and seeks to invest up to thirty percent of the Company's assets in unquoted companies, while allowing an exposure of up to forty percent in unquoted companies (at the time of investment and after allowing for valuation write-ups and further follow-on investments). The fund typically invests in the United States, but seeks the best investments worldwide and so may also invest in Western Europe, Australia, and Asia. It typically invests between $1 million and $4 million in its portfolio companies. It exits its unquoted investments through the sale of these companies to strategic buyers including major pharmaceutical companies or, in some cases, and through a flotation.


See More Headlines

Industry, Sector and Symbol

Asset Management
Year Founded

Sales & Book Value

Annual Sales
£32.03 million
Cash Flow
GBX 3.98 per share
Book Value
GBX 782.40 per share


Pretax Margin




Free Float
Market Cap
£253.49 million
Not Optionable


Overall MarketRank

2.51 out of 5 stars

Analyst Opinion: 1.5Community Rank: 5.0Dividend Strength: 2.5Insider Behavior: 1.7Valuation: 1.9 5 -4 -3 -2 -1 -

International Biotechnology Trust (LON:IBT) Frequently Asked Questions

Is International Biotechnology Trust a buy right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for International Biotechnology Trust in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" International Biotechnology Trust stock.
View analyst ratings for International Biotechnology Trust
or view top-rated stocks.

How often does International Biotechnology Trust pay dividends? What is the dividend yield for International Biotechnology Trust?

International Biotechnology Trust announced a dividend on Wednesday, December 8th. Shareholders of record on Thursday, December 30th will be given a dividend of GBX 15.70 per share on Friday, January 28th. This represents a yield of 2.14%. The ex-dividend date is Thursday, December 30th. This is a boost from International Biotechnology Trust's previous dividend of GBX 14.20. The official announcement can be seen at this link.
View International Biotechnology Trust's dividend history

Is International Biotechnology Trust a good dividend stock?

International Biotechnology Trust pays an annual dividend of GBX 0.28 per share and currently has a dividend yield of 4.99%. IBT has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio of International Biotechnology Trust is 0.41%. This payout ratio is at a healthy, sustainable level, below 75%.
View International Biotechnology Trust's dividend history.

What price target have analysts set for IBT?

1 brokers have issued 12 month target prices for International Biotechnology Trust's stock. Their forecasts range from GBX 260 to GBX 260. On average, they anticipate International Biotechnology Trust's stock price to reach GBX 260 in the next year. This suggests that the stock has a possible downside of 58.1%.
View analysts' price targets for International Biotechnology Trust
or view top-rated stocks among Wall Street analysts.

Who are International Biotechnology Trust's key executives?
International Biotechnology Trust's management team includes the following people:
  • Ms. Lucy Costa Duarte, Head of Investor Relations
  • Ms. Catherine Bingham M.B.A., Managing Partner (Age 55)
  • Ms. Ailsa Craig, Investment Mang.
  • Mr. Marek Poszepczynski, Investment Mang.
  • Claire Jackson, Company Sec.
  • Dr. Carl Harald Janson, Lead Investment Mang.
What other stocks do shareholders of International Biotechnology Trust own?

Based on aggregate information from My MarketBeat watchlists, some companies that other International Biotechnology Trust investors own include Oxford Pharmascience Group (OXP), Provident Financial (PFG), 1724525 (ADN.L) (ADN), The Berkeley Group (BKG), GLI Finance (GLIF), Hurricane Energy (HUR), Phoenix Group (PHNX), Riverstone Energy (RSE), Scirocco Energy Plc (SOLO.L) (SOLO) and Sirius Minerals (SXX).

What is International Biotechnology Trust's stock symbol?

International Biotechnology Trust trades on the London Stock Exchange (LON) under the ticker symbol "IBT."

How do I buy shares of International Biotechnology Trust?

Shares of IBT and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is International Biotechnology Trust's stock price today?

One share of IBT stock can currently be purchased for approximately GBX 620.

How much money does International Biotechnology Trust make?

International Biotechnology Trust has a market capitalization of £253.49 million and generates £32.03 million in revenue each year.

What is International Biotechnology Trust's official website?

The official website for International Biotechnology Trust is www.ibtplc.com.

How can I contact International Biotechnology Trust?

International Biotechnology Trust's mailing address is 10 Harewood Avenue, LONDON, NW1 6AA, United Kingdom. The company can be reached via phone at 44 20 7421 7070.

This page was last updated on 5/22/2022 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.